Amir Khammari
Overview
Explore the profile of Amir Khammari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
144
Citations
2238
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lancien U, Sbeih M, Poinas A, Perrot P, Aractingi S, Khammari A, et al.
Burns Trauma
. 2025 Feb;
13:tkae086.
PMID: 39963607
No abstract available.
2.
Bossard C, Salhi Y, Khammari A, Brousseau M, Le Corre Y, Salhi S, et al.
J Eur Acad Dermatol Venereol
. 2025 Jan;
PMID: 39853986
Background: There is a need to improve risk stratification of primary cutaneous melanomas to better guide adjuvant therapy. Taking into account that haematoxylin and eosin (HE)-stained tumour tissue contains a...
3.
Vitek L, Goronflot T, Dutriaux C, Deleuze A, Le Corre Y, Duval-Modeste A, et al.
Acta Derm Venereol
. 2024 Dec;
104:adv41297.
PMID: 39670438
Metastatic uveal melanoma is a rare disease with a poor prognosis. Usual treatments have not proven effective. Tebentafusp, a bispecific protein targeting melanoma cells and T lymphocytes, is the first...
4.
Jirovec E, Quixabeira D, Clubb J, Pakola S, Kudling T, Arias V, et al.
J Exp Clin Cancer Res
. 2024 Nov;
43(1):297.
PMID: 39506856
Background: A limitation of approved oncolytic viruses is their requirement for intratumoral (i.t.) injection. TILT-123 (igrelimogene litadenorepvec, Ad5/3-E2F-D24-hTNFα-IRES-hIL-2) is a chimeric oncolytic adenovirus suitable for intravenous (i.v.) delivery due to...
5.
Cheung C, Lancien U, Corvec S, Mengeaud V, Mias C, Veziers J, et al.
Exp Dermatol
. 2024 Aug;
33(8):e15150.
PMID: 39113601
Acne is a chronic inflammatory skin condition that involves Cutibacterium acnes (C. acnes), which is classified into six main phylotypes (IA, IA, IB, IC, II and III). Acne development is...
6.
Ruffier dEpenoux L, Fayoux E, Veziers J, Dagnelie M, Khammari A, Dreno B, et al.
Int J Dermatol
. 2024 May;
63(11):1541-1550.
PMID: 38760974
Background: Acne vulgaris is a chronic inflammatory dermatosis. Cutibacterium acnes plays a crucial role in the acne pathophysiology. Recent works present evidence of C. acnes growing as a biofilm in...
7.
Dreno B, Nguyen J, Hainaut E, Machet L, Leccia M, Beneton N, et al.
Acta Derm Venereol
. 2024 Feb;
104:adv26002.
PMID: 38380975
Acne in adult females is triggered mainly by hormones. Doxycycline is a reference treatment in acne. Spironolactone targets the androgen receptor of sebaceous glands and is prescribed off-label for female...
8.
Khammari A, Kerob D, Demessant A, Niore M, Dreno B
J Cosmet Dermatol
. 2023 Dec;
23(4):1313-1319.
PMID: 38102855
Introduction: Topical retinoids cause retinoid-induced skin discomfort (RISD) mainly during the first weeks of use leading to noncompliance and premature treatment discontinuation. A dermocosmetic (DC) may help to reduce treatment-related...
9.
Hazard M, Duval F, Dutriaux C, Beylot-Barry M, Pham-Ledard A, Quereux G, et al.
J Neurol
. 2023 Dec;
271(3):1473-1482.
PMID: 38052771
No abstract available.
10.
Khammari A, Demessant-Flavigny A, Kerob D, Seite S, Dreno B
J Drugs Dermatol
. 2023 Dec;
22(12):1172-1177.
PMID: 38051857
Background: A dermocosmetic (DC) containing salicylic acid, niacinamide, and thermal spring water has been developed for the management of mild to moderate acne. Aim: To assess the efficacy of DC...